{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:39:38Z","timestamp":1783615178858,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1642,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1469-0691.2009.02922.x","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T13:18:19Z","timestamp":1250774299000},"page":"657-662","source":"Crossref","is-referenced-by-count":13,"title":["Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein--Barr viraemia"],"prefix":"10.1016","volume":"16","author":[{"given":"T.","family":"Martelius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.-J.","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nihtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lappalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.02922.x_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein\u2013Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/522531","article-title":"Epstein\u2013Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients","volume":"45","author":"Aalto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","article-title":"Ratio between Epstein\u2013Barr viral load and anti\u2010Epstein\u2013Barr virus specific T\u2010cell response as a predictive marker of posttransplant lymphoproliferative disease","volume":"73","author":"Smets","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00007890-200109270-00006","article-title":"Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein\u2013Barr viral load by using real\u2010time quantitative polymerase chain reaction","volume":"72","author":"Wagner","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein\u2013Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1078-0432.CCR-05-2008","article-title":"Plasma Epstein\u2013Barr virus (EBV) DNA is a biomarker for EBV\u2010positive Hodgkin\u2019s lymphoma","volume":"12","author":"Gandhi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3","article-title":"Immunoreactivation of Epstein\u2013Barr virus due to cytomegalovirus primary infection","volume":"56","author":"Aalto","year":"1998","journal-title":"J Med Virol"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2006.06.012","article-title":"Monitoring of EBV\u2010DNAemia by quantitative real\u2010time PCR after adult liver transplantation","volume":"37","author":"Loginov","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1386-6532(03)00022-2","article-title":"Lymphoproliferative disease after allogeneic stem cell transplantation\u2010\u2010pre\u2010emptive diagnosis by quantification of Epstein\u2013Barr virus DNA in serum","volume":"28","author":"Aalto","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein\u2013Barr virus load by using a real\u2010time PCR assay","volume":"37","author":"Kimura","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/491740","article-title":"A prospective clinical study of Epstein\u2013Barr virus and host interactions during acute infectious mononucleosis","volume":"192","author":"Balfour","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/asheducation-2007.1.332","article-title":"Management of infectious complications in patients with chronic lymphocytic leukemia","volume":"2007","author":"Morrison","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib14","first-page":"2028","article-title":"Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients","volume":"63","author":"Chan","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1469-0691.2009.02922.x_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu Rev Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14617079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14617079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:48:47Z","timestamp":1590076127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14617079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1198743X14617079"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02922.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}